AmeriPath Restructures Sales and Marketing Organization; Entities Dedicated to Referring Physician Specialties.Business Editors and Health/Medical Writers RIVIERA BEACH Riviera Beach (rəvēr`ə), resort city (1990 pop. 27,639), Palm Beach co., SE Fla., on Lake Worth (a lagoon); inc. 1922. Research and development firms are located in the growing city. , Fla.--(BUSINESS WIRE)--Jan. 15, 2001 AmeriPath Inc, (Nasdaq:PATH), the nation's largest company focused on providing anatomic pathology, cancer diagnostic and related healthcare information services See Information Systems. , announced today that it has divided its sales and marketing organizations into two separate divisions. After the completion of market research, including customer focus groups and the demographic distribution of patients and referring physicians, along with closely examining the current business model, two distinct field sales organizations have been created to provide dedicated service and support to referring physicians along specialty lines. Both organizations will be under the direction of Bruce Walton Bruce Kenneth Walton (born December 25, 1962 in Bakersfield, California) is an American bullpen coach currently working for the Toronto Blue Jays. Bruce Walton pitched in Major League Baseball from 1991 to 1994, playing with the Oakland Athletics, Montreal Expos, and , Vice President of Sales, Marketing and Contracting. Dermpath Diagnostics, which will be led by Annette L. Bell, Vice President and General Manager, will focus on servicing and growing the national skin pathology market comprised of dermatologists, plastic surgeons plastic surgeon A surgeon specialized in reconstruction or cosmetic enhancement of various body regions, most commonly the face–nose, chin, and cheeks, breasts and buttocks; PSs remove fat deposits through liposuction; PSs reduce scarring or disfigurement , family practitioners family practitioner n. Abbr. FP See family physician. , otolaryngologists, and podiatrists. This division, which represents AmeriPath's 67 board-certified dermatopathologists, will expand its sales and marketing initiative throughout the U.S. market. The existing AmeriPath field sales organization, led by Ed Dooling, Vice President and General Manager, has the responsibility for servicing and growing the outpatient anatomic pathology market with urologists, gastroenterologists, gynecologists, surgery centers, oncologists and any specialist requiring esoteric laboratory testing, which is provided through our Center for Advanced Diagnostics. AmeriPath's Contracting Division will support both organizations in managed care contracting efforts in the field. AmeriPath's Chairman and Chief Executive Officer, James C. New, commented, "These newly developed sales and marketing divisions are comprised of over 40 sales professionals who are dedicated to responding to the specific needs of our referring physicians and their patients. This strategic positioning enables AmeriPath to better serve our customers and meet or exceed our same store growth initiatives for 2001." AmeriPath, Inc. is the nation's largest company focused on providing anatomic pathology, cancer diagnostic and related healthcare information services to physicians, hospitals, national clinical laboratories and managed care organizations. The Company's 426 physicians provide medical services through 42 outpatient pathology laboratories, 224 hospital inpatient laboratories, and 64 outpatient surgery Outpatient Surgery, also referred to as ambulatory surgery or same-day surgery, is surgery that does not require an overnight hospital stay. The term “outpatient” arises from the fact that surgery patients may go home do not need an overnight hospital centers in 21 states. The statements of James C. New and other statements contained in this press release are "forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. " which are based on current beliefs and expectations. Past performance is not necessarily indicative of future results. In addition, forward-looking statements - which are identified by words such as "may", "should", "believe," "expect," "anticipate" and similar expressions -- are subject to a number of risks and uncertainties which could cause actual results to differ materially from historical results or those expected or anticipated. These include risks and uncertainties relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc satisfaction of closing conditions, demand for pathology services, pricing, federal and state regulation (and compliance), reimbursement Reimbursement Payment made to someone for out-of-pocket expenses has incurred. rates, government and third party payments, the ability to attract, motivate, and retain pathologists, dependence upon pathologists and contracts, the development and expansion of managed care and national clinical lab contracts, completion and integration of acquisitions and affiliations (and achievement of planned or expected synergies), competitive factors and technology. Further information regarding risks, uncertainties and other factors that could affect the Company's financial results, or could cause actual results to differ materially from those expected or anticipated, are included in the Company's Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended December 31, 1999 and subsequent filings with the SEC. Editor's Note Editor's Note (foaled in 1993 in Kentucky) is an American thoroughbred Stallion racehorse. He was sired by 1992 U.S. Champion 2 YO Colt Forty Niner, who in turn was a son of Champion sire Mr. Prospector and out of the mare, Beware Of The Cat. Trained by D. : This release is also available at http://www.ameripath.com |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion